A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®

Clinical trial NCT07062978 · RECRUITING

Trial details

NCT number: NCT07062978
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Postmenopausal Women With Osteoporosis at High Risk of Fracture

Start date: 2025-06-27
Primary completion: 2027-01-01
Enrollment: 278

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.